Sunday, June 26, 2022

ALS drug Albrioza approved in Canada while still under review in the US

- Advertisement -
- Advertisement -



An experimental drug for the neurological condition ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the US Food and Drug Administration has raised questions about its effectiveness.

- Advertisement -
Latest news
- Advertisement -
Related news
- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here